COCRYSTAL PHARMA, INC. Current State and Local Tax Expense (Benefit)
COCRYSTAL PHARMA, INC. (COCP) reported Current State and Local Tax Expense (Benefit) of $19.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-21.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2018-03-21
- COCRYSTAL PHARMA, INC. current state and local tax expense (benefit) for fiscal 2016 was $19.00K, a 0.00% change from fiscal 2015.
- COCRYSTAL PHARMA, INC. current state and local tax expense (benefit) for fiscal 2015 was $19.00K, a 850.00% increase from fiscal 2014.
- COCRYSTAL PHARMA, INC. current state and local tax expense (benefit) for fiscal 2014 was $2.00K.
| Period end | Current State and Local Tax Expense (Benefit) 12 month |
|---|---|
| 2016-12-31 | $19.00K 10-K · filed 2018-03-21 |
| 2015-12-31 | $19.00K 10-K · filed 2018-03-21 |
| 2014-12-31 | $2.00K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |